Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
Holders of 5% or more of FBRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Forte Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Tybourne Capital Management (HK) Ltd | 13G/A | 9.99%1.27M shares | 0.00 ppfrom 9.99% | Feb 14, 20243 filings | Aug 4, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 9.30%1.89M shares | +6.80 ppfrom 2.50% | Feb 14, 20257 filings | Aug 13, 2026 | SEC |
| MPM Oncology Impact Management LP | 13G | 7.20%1.00M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| OrbiMed Advisors LLC | 13G/A | 6.20%1.26M shares | +1.90 ppfrom 4.30% | Feb 12, 20215 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.90%1.20M shares | New | Jul 28, 20261 filing | Jul 28, 2026 | SEC |
| Affinity Asset Advisors, LLC | 13G/A | 5.60%1.15M shares | −1.70 ppfrom 7.30% | Dec 23, 20254 filings | Aug 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
105 Schedule 13D and 13G filings on Forte Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 22, 2021 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Oliveira Steven Michael | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | OrbiMed Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 1, 2021 | Franklin Resources Inc | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Forte Biosciences, Inc. shares.
No Form 144 notices for Forte Biosciences, Inc. are on file.